![John W. Gillard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John W. Gillard
Hoofd Techniek/Wetenschap/O&O bij Aegera Therapeutics, Inc.
Actieve functies van John W. Gillard
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van John W. Gillard
Eerdere bekende functies van John W. Gillard
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GLYCODesign, Inc.
![]() GLYCODesign, Inc. Pharmaceuticals: MajorHealth Technology GLYCODesign, Inc. develops pharmaceutical products. The company engages in the discovery and development of novel therapeutics for life-threatening diseases such as cancer, infectious diseases, inflammation, and cardiovascular diseases. GLYCODesign focuses on inhibiting the enzymes that produce the abnormal carbohydrates. The company was founded by Jeremy Carver in 1993 and is headquartered in Toronto, Canada. | Directeur/Bestuurslid | 01-01-1997 | 01-01-2003 |
Apoptogen, Inc. | President | 01-01-1997 | 01-01-2000 |
Ottawa Life Sciences Council | Directeur/Bestuurslid | 01-01-1997 | 01-01-2000 |
Kinetek Pharmaceuticals, Inc. | Voorzitter | 01-01-1998 | 01-01-1999 |
Canadian Genetics Diseases Network
![]() Canadian Genetics Diseases Network Miscellaneous Commercial ServicesCommercial Services Canadian Genetics Diseases Network provides research and development services to the healthcare industry. The company is headquartered in Vancouver, Canada. | Directeur/Bestuurslid | 01-01-1992 | 01-01-1999 |
Biochem Pharma, Inc.
![]() Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Hoofd Techniek/Wetenschap/O&O | 01-01-1991 | 01-01-1996 |
MERCK & CO., INC. | Corporate Officer/Principal | 01-01-1980 | 01-01-1991 |
Nuchem Therapeutics, Inc.
![]() Nuchem Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nuchem Therapeutics, Inc. provides financial investment services. The firm offers medicinal chemistry services and expertise, biochemistry support, custom and contract synthesis and assay development. The company was founded in 2011 and is headquartered in Montreal, Canada. | Directeur/Bestuurslid | - | - |
░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van John W. Gillard
University of Tasmania | Doctorate Degree |
Statistieken
Internationaal
Canada | 10 |
Verenigde Staten | 3 |
Australië | 2 |
Operationeel
Director/Board Member | 6 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 8 |
Commercial Services | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Bedrijven in privébezit | 10 |
---|---|
GLYCODesign, Inc.
![]() GLYCODesign, Inc. Pharmaceuticals: MajorHealth Technology GLYCODesign, Inc. develops pharmaceutical products. The company engages in the discovery and development of novel therapeutics for life-threatening diseases such as cancer, infectious diseases, inflammation, and cardiovascular diseases. GLYCODesign focuses on inhibiting the enzymes that produce the abnormal carbohydrates. The company was founded by Jeremy Carver in 1993 and is headquartered in Toronto, Canada. | Health Technology |
IBEX Technologies, Inc.
![]() IBEX Technologies, Inc. Medical SpecialtiesHealth Technology IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The firm also specializes in the custom aliquoting, filling, and lyophilization of enzymes in diagnostic disposables for medical devices. Its products include glycobiology enzymes from flavobacterium heparinum, collagen assays, collagen antibodies, and diamine oxidase liquid. The company was founded by Robert A. Heft on April 10, 1972 and is headquartered in Montréal, Canada. | Health Technology |
Kinetek Pharmaceuticals, Inc. | Health Technology |
Biochem Pharma, Inc.
![]() Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Health Technology |
Aegera Therapeutics, Inc.
![]() Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Health Technology |
Canadian Genetics Diseases Network
![]() Canadian Genetics Diseases Network Miscellaneous Commercial ServicesCommercial Services Canadian Genetics Diseases Network provides research and development services to the healthcare industry. The company is headquartered in Vancouver, Canada. | Commercial Services |
Apoptogen, Inc. | |
Molecular Templates, Inc. /Old/
![]() Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
Nuchem Therapeutics, Inc.
![]() Nuchem Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nuchem Therapeutics, Inc. provides financial investment services. The firm offers medicinal chemistry services and expertise, biochemistry support, custom and contract synthesis and assay development. The company was founded in 2011 and is headquartered in Montreal, Canada. | Commercial Services |
Ottawa Life Sciences Council |
- Beurs
- Insiders
- John W. Gillard
- Ervaring